| Product NDC: | 60505-2529 |
| Proprietary Name: | ziprasidone hydrochloride |
| Non Proprietary Name: | Ziprasidone HCl |
| Active Ingredient(s): | 40 mg/1 & nbsp; Ziprasidone HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-2529 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077561 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120514 |
| Package NDC: | 60505-2529-0 |
| Package Description: | 8 BLISTER PACK in 1 CARTON (60505-2529-0) > 10 CAPSULE in 1 BLISTER PACK |
| NDC Code | 60505-2529-0 |
| Proprietary Name | ziprasidone hydrochloride |
| Package Description | 8 BLISTER PACK in 1 CARTON (60505-2529-0) > 10 CAPSULE in 1 BLISTER PACK |
| Product NDC | 60505-2529 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ziprasidone HCl |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120514 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | ZIPRASIDONE HYDROCHLORIDE |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |